Seiichi Okabe

The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1

Junko H. Ohyashiki, Chiaki Kobayashi, Ryoko Hamamura et al. · Cancer Science · 2009 · 133 citations · Full text

Hematological Malignancy, Signal Transduction, Myeloid Leukemia Cells +14

Stromal cell–derived factor-1α/CXCL12–induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1

Seiichi Okabe, Seiji Fukuda, Young‐June Kim et al. · Blood · 2004 · 60 citations · Full text

Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemia-lymphoma.

M Shimoyama, K Minato, Kensei Tobinai et al. · PubMed · 1983 · 46 citations

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +14

Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome–positive acute lymphoblastic leukemia

Shoji Saito, Yozo Nakazawa, Akane Sueki et al. · Cytotherapy · 2014 · 46 citations

Hematological Malignancy, Lymphocyte Development, Immunology +7

Combination of Ponatinib with Hedgehog Antagonist Vismodegib for Therapy-Resistant BCR-ABL1–Positive Leukemia

Seiichiro Katagiri, Tetsuzo Tauchi, Seiichi Okabe et al. · Clinical Cancer Research · 2013 · 43 citations